Delivery Order SPE2DB22D3011-SPE2DB26FP7FE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,762.31 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,502.00 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on April 29, 2025, is scheduled for ultimate completion by April 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for $6,797.70 to supply HUMIRA (CF) Pen 40 mg/0.4 mL units. This non-competitive delivery order was issued under a firm fixed price structure with a completion date of July 31, 2025, and represents a single transaction on the company's broader pharmaceutical supply contract with DLA. The place of performance is located at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,445.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,265.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-competitive delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products. This is a firm fixed price, competitive delivery order with no set-aside designation, with an ultimate completion date of September 25, 2025. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,156.39 and is scheduled for completion by September 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,265.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, awarded on April 21, 2025, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by April 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,719.71 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product for treating autoimmune conditions. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency (DLA) awarded a $5,066.24 delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, was competitively awarded without a set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7FEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,784.59 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on October 16, 2025, with completion expected by October 17, 2025, was awarded without set-aside restrictions through competitive procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical supply needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive contract vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a prime pharmaceutical vendor reflects its established capability to fulfill federal medical procurement requirements and deliver critical medications across multiple therapeutic domains to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 10/16/25 |